Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Statistics

Total Valuation

EPRX has a market cap or net worth of $325.51 million. The enterprise value is $267.16 million.

Market Cap	325.51M
Enterprise Value	267.16M

Important Dates

The last earnings date was Tuesday, November 4, 2025, after market close.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

EPRX has 50.65 million shares outstanding. The number of shares has increased by 13.17% in one year.

Current Share Class	50.65M
Shares Outstanding	50.65M
Shares Change (YoY)	+13.17%
Shares Change (QoQ)	+2.75%
Owned by Insiders (%)	19.87%
Owned by Institutions (%)	25.77%
Float	35.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.68
P/TBV Ratio	5.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.98, with a Debt / Equity ratio of 0.00.

Current Ratio	23.98
Quick Ratio	23.38
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-83.64

Financial Efficiency

Return on equity (ROE) is -61.02% and return on invested capital (ROIC) is -38.47%.

Return on Equity (ROE)	-61.02%
Return on Assets (ROA)	-36.21%
Return on Invested Capital (ROIC)	-38.47%
Return on Capital Employed (ROCE)	-33.60%
Revenue Per Employee	n/a
Profits Per Employee	-$960,907
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, EPRX has paid $9,556 in taxes.

Income Tax	9,556
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.92% in the last 52 weeks. The beta is 1.50, so EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	+107.92%
50-Day Moving Average	5.84
200-Day Moving Average	4.68
Relative Strength Index (RSI)	59.70
Average Volume (20 Days)	119,634

Short Selling Information

The latest short interest is 265,495, so 0.52% of the outstanding shares have been sold short.

Short Interest	265,495
Short Previous Month	296,130
Short % of Shares Out	0.52%
Short % of Float	0.76%
Short Ratio (days to cover)	4.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.75M
Pretax Income	-29.41M
Net Income	-31.71M
EBITDA	-29.60M
EBIT	-29.75M
Earnings Per Share (EPS)	-$0.88

Balance Sheet

The company has $88.96 million in cash and $170,603 in debt, giving a net cash position of $88.79 million or $1.75 per share.

Cash & Cash Equivalents	88.96M
Total Debt	170,603
Net Cash	88.79M
Net Cash Per Share	$1.75
Equity (Book Value)	88.44M
Book Value Per Share	1.15
Working Capital	87.59M

Cash Flow

In the last 12 months, operating cash flow was -$24.80 million and capital expenditures -$439,961, giving a free cash flow of -$25.24 million.

Operating Cash Flow	-24.80M
Capital Expenditures	-439,961
Free Cash Flow	-25.24M
FCF Per Share	-$0.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.17%
Shareholder Yield	-13.17%
Earnings Yield	-9.74%
FCF Yield	-7.75%

Analyst Forecast

The average price target for EPRX is $11.50, which is 79.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	79.55%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2